{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:42:22Z","timestamp":1792806142652,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"VANDERBILT UNIVERSITY MEDICAL CENTER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR084312"],"award-info":[{"award-number":["R01 AR084312"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UC2 AR081029"],"award-info":[{"award-number":["UC2 AR081029"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UC2 AR081033"],"award-info":[{"award-number":["UC2 AR081033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR073196"],"award-info":[{"award-number":["R01 AR073196"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AR070590"],"award-info":[{"award-number":["P50 AR070590"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI30025"],"award-info":[{"award-number":["R01 AI30025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI79251"],"award-info":[{"award-number":["P01 AI79251"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jid.2025.09.005","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:08:34Z","timestamp":1761617314000},"page":"322-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Reevaluating the Imiquimod Model: A Barrier to Translational Progress in Psoriasis"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1859-4895","authenticated-orcid":false,"given":"Catherine C.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0003-3499","authenticated-orcid":false,"given":"Ian M.","family":"Zwerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-0812","authenticated-orcid":false,"given":"Johann E.","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1907-2621","authenticated-orcid":false,"given":"Nicole L.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.09.005_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4049\/immunohorizons.2300003","article-title":"Guselkumab more effectively neutralizes psoriasis-associated histologic, transcriptomic, and clinical measures than ustekinumab","volume":"7","author":"Campbell","year":"2023","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.jid.2025.09.005_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1574455","article-title":"Highly differentiated T cells link systemic and vascular inflammation in a mouse model of recurrent psoriasis","volume":"16","author":"Casciano","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.09.005_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq7991","article-title":"Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems","volume":"8","author":"Castillo","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jid.2025.09.005_bib4","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","article-title":"Mouse models of psoriasis: a comprehensive review","volume":"142","author":"Gangwar","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.09.005_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2017.07.045","article-title":"Toll-like receptor 7\/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects","volume":"141","author":"Garzorz-Stark","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.09.005_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/ni.2585","article-title":"Deficiency in IL-17-committed V\u03b34(+) \u03b3\u03b4 T cells in a spontaneous Sox13-mutant CD45.1(+) congenic mouse substrain provides protection from dermatitis","volume":"14","author":"Gray","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2025.09.005_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41419-024-06583-z","article-title":"Single-cell RNA-seq reveals keratinocyte and fibroblast heterogeneity and their crosstalk via epithelial-mesenchymal transition in psoriasis","volume":"15","author":"Guo","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2025.09.005_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","article-title":"The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal","volume":"137","author":"Hawkes","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.09.005_bib9","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.2147\/JIR.S379349","article-title":"Single-cell RNA sequencing reveals the immune cell profiling in IMQ induced psoriasis-like model","volume":"15","author":"Jin","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jid.2025.09.005_bib10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jaci.2019.04.029","article-title":"IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis","volume":"144","author":"Krueger","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.09.005_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12865-021-00401-3","article-title":"Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist","volume":"22","author":"Li","year":"2021","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jid.2025.09.005_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101582","article-title":"Single-cell profiling reveals divergent, globally patterned immune responses in murine skin inflammation","volume":"23","author":"Liu","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.jid.2025.09.005_bib13","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41467-023-39020-4","article-title":"Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis","volume":"14","author":"Ma","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2025.09.005_bib14","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ajpath.2018.02.005","article-title":"Imiquimod-induced psoriasis-like skin lesions do not accelerate atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"188","author":"Madsen","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2025.09.005_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.764557","article-title":"Different spatial and temporal roles of monocytes and monocyte-derived cells in the pathogenesis of an imiquimod induced lupus model","volume":"13","author":"Nomura","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.09.005_bib16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1248\/bpb.b25-00060","article-title":"Adipose-derived mesenchymal stromal\/stem cells reduce inflammatory responses and partially alleviate skin symptoms in imiquimod-induced psoriasis-like dermatitis model mice","volume":"48","author":"Ogino","year":"2025","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jid.2025.09.005_bib17","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Ror\u03b3t+ innate lymphocytes and \u03b3\u03b4 T cells initiate psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2025.09.005_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/BOR.0000000000001093","article-title":"What are mice teaching us about psoriatic arthritis?","volume":"37","author":"Randon","year":"2025","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jid.2025.09.005_bib19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jid.2018.09.021","article-title":"Antagonization of IL-17A attenuates skin inflammation and vascular dysfunction in mouse models of psoriasis","volume":"139","author":"Sch\u00fcler","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.09.005_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jdermsci.2019.07.006","article-title":"Anti-IL-17A and IL-23p19 antibodies but not Anti-TNF\u03b1 antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis","volume":"95","author":"Shimizu","year":"2019","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2025.09.005_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084634","article-title":"Suppression of molecular inflammatory pathways by Toll-like receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation","volume":"8","author":"Su\u00e1rez-Fari\u00f1as","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2025.09.005_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018266","article-title":"Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis","volume":"6","author":"Swindell","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2025.09.005_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13073-017-0415-3","article-title":"Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis","volume":"9","author":"Swindell","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.jid.2025.09.005_bib24","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/ced\/llae152","article-title":"Cedirogant in adults with psoriasis: a phase II, randomized, placebo-controlled clinical trial","volume":"49","author":"Tyring","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2025.09.005_bib25","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.09.005_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/bjd.13236","article-title":"Aldara\u00ae-induced skin inflammation: studies of patients with psoriasis","volume":"172","author":"Vinter","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.09.005_bib27","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.38298","article-title":"Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic lupus erythematosus","volume":"66","author":"Yokogawa","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2025.09.005_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jpha.2023.05.009","article-title":"Small molecule inhibitors of ROR\u03b3t for Th17 regulation in inflammatory and autoimmune diseases","volume":"13","author":"Zeng","year":"2023","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.jid.2025.09.005_bib29","article-title":"Zdhhc2 is essential for plasmacytoid dendritic cells mediated inflammatory response in psoriasis","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.09.005_bib30","article-title":"Adipose tissue macrophage-derived PPBP exacerbates psoriasis-associated atherosclerosis by inducing mitochondrial dysfunction in aortic endothelial cells","author":"Zhu","year":"2025","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25024297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25024297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:24:19Z","timestamp":1773923059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25024297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022202X25024297"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.09.005","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reevaluating the Imiquimod Model: A Barrier to Translational Progress in Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}